SEC Form 4 · accession 0001127602-18-009036

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chairman & CEO · Director

Period of report

Feb 26, 2018

Accepted (ET)

Feb 28, 2018 · 3:25 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001100682

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Feb 26, 2018	S	200	$107.13	D	320,511	D
Common Stock	Feb 26, 2018	S	116	$107.135	D	320,395	D
Common Stock	Feb 26, 2018	S	188	$107.14	D	320,207	D
Common Stock	Feb 26, 2018	S	100	$107.16	D	320,107	D
Common Stock	Feb 26, 2018	S	200	$107.17	D	319,907	D
Common Stock	Feb 26, 2018	S	100	$107.185	D	319,807	D
Common Stock	Feb 26, 2018	S	700	$107.19	D	319,107	D
Common Stock	Feb 26, 2018	S	100	$107.21	D	319,007	D
Common Stock	Feb 26, 2018	S	100	$107.22	D	318,907	D
Common Stock	Feb 26, 2018	S	100	$107.225	D	318,807	D
Common Stock	Feb 26, 2018	S	12	$107.235	D	318,795	D
Common Stock	Feb 26, 2018	S	90	$107.24	D	318,705	D
Common Stock	Feb 26, 2018	S	200	$107.255	D	318,505	D
Common Stock	Feb 26, 2018	S	200	$107.27	D	318,305	D
Common Stock	Feb 26, 2018	S	100	$107.35	D	318,205	D
Common Stock	Feb 26, 2018	S	200	$107.36	D	318,005	D
Common Stock	Feb 26, 2018	S	100	$107.42	D	317,905	D
Common Stock	Feb 26, 2018	S	200	$107.44	D	317,705	D
Common Stock	Feb 26, 2018	S	100	$107.52	D	317,605	D
Common Stock	Feb 26, 2018	S	400	$107.525	D	317,205	D
Common Stock	Feb 26, 2018	S	200	$107.54	D	317,005	D
Common Stock	Feb 26, 2018	S	100	$107.545	D	316,905	D
Common Stock	Feb 26, 2018	S	100	$107.59	D	316,805	D
Common Stock	Feb 26, 2018	S	93	$107.61	D	316,712	D

No Table II lines on this filing.